A new standard in early detection of dementia
ELEarly Dementia. A blood test for early dementia risk screening.
A new standard in early detection of dementia
ELEarly Dementia. A blood test for early dementia risk screening.
Our Purpose
Our Mission
Detecting dementia before symptoms appear, putting science at the service of society.
Early Detection
The cornerstone of ELE Biotech is the early detection of neurodegenerative diseases through our biomarker.
Life Quality
We firmly believe that early dementia detection improves the outlook and quality of life of patients and those around them.
Enhanced Research
ELE Biotech is a start-up with a strong focus on R&D in biomarkers and diagnostics. Continuous improvement is our only option.
The data speaks
Quantitative Evidence
The problem of dementia is urgent and global. The numbers speak for themselves.
×3 by 2050
People are currently living with dementia, and this figure is expected to triple by 2050
Of cases remain undiagnosed, delaying referral, treatment, and the social support patients need
From the first symptoms to diagnosis, a key window for early detection
Who We Are
Our Team
A multidisciplinary team with the perfect combination of science and business expertise to bring early diagnosis to market.
The founders have been friends since they were two years old. They built their careers separately: one becoming a scientist at centres of excellence and the other creating and managing companies, but have decided to join forces to address an unmet need: early dementia screening. The multidisciplinary team has the perfect combination of experience to bring our device to market through ELE Biotech.
Rocío de Dios Segovia
Office Manager
Jesús Ávila de Grado
Expert Advisor
You don't have to be the best at anything,
just the happiest at everything
Ready to learn more?
Want to learn about ELEarly Dementia?
We put science at the service of society. Contact us and discover how ELE Biotech is changing dementia diagnosis.
Contact us